A case of hepatocyte nuclear factor-1β (TCF2) maturity onset diabetes of the young misdiagnosed as type 1 diabetes and treated unnecessarily with insulin

Journal of Diabetes

Volumn 5, Issue 4, 2013, Pages 462-464

  Thirumalai, Arthi ^a   Holing, Emily ^a   Brown, Zane ^a   Gilliam, Lisa K ^a  

^a UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; GLUCOSE; HEMOGLOBIN A1C; HEPATOCYTE NUCLEAR FACTOR 1BETA; INSULIN; METFORMIN; TRANSCRIPTION FACTOR;

ADD ON THERAPY; ADULT; ARTICLE; BLOOD GLUCOSE MONITORING; CASE REPORT; CAUCASIAN; DIABETIC KETOACIDOSIS; DIAGNOSTIC ERROR; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; EXON; FEMALE; GENE MUTATION; GENETIC SCREENING; GESTATIONAL AGE; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; KIDNEY CYST; NON INSULIN DEPENDENT DIABETES MELLITUS; PREMATURE FETUS MEMBRANE RUPTURE; PRIORITY JOURNAL; PUERPERIUM;

DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIAGNOSTIC ERRORS; FEMALE; HEPATOCYTE NUCLEAR FACTOR 1-BETA; HUMANS; INSULIN; MEDICAL FUTILITY; METFORMIN; PREGNANCY; PREGNANCY IN DIABETICS; YOUNG ADULT;

EID: 84887019989     PISSN: 17530393     EISSN: 17530407     Source Type: Journal    
DOI: 10.1111/1753-0407.12043     Document Type: Article

References (10)

1. Bingham C, Bulman MP, Ellard S etal. Mutations in the hepatocyte nuclear factor-1beta gene are associated with familial hypoplastic glomerulocystic kidney disease. Am J Hum Genet. 2001; 68: 219-224.
2. Thomas CP, Erlandson JC, Edghill EL, Hattersley AT, Stolpen AH. A genetic syndrome of chronic renal failure with multiple renal cysts and early onset diabetes. Kidney Int. 2008; 74: 1094-1099.
3. Hattersley AT, Pearson ER. Minireview: Pharmacogenetics and beyond: The interaction of therapeutic response, beta-cell physiology, and genetics in diabetes. Endocrinology. 2006; 147: 2657-2663.
4. Pearson ER, Starkey BJ, Powell RJ, Gribble FM, Clark PM, Hattersley AT. Genetic cause of hyperglycaemia and response to treatment in diabetes. Lancet. 2003; 362: 1275-1281.
5. Fajans SS, Brown MB. Administration of sulfonylureas can increase glucose-induced insulin secretion for decades in patients with maturity-onset diabetes of the young. Diabetes Care. 1993; 16: 1254-1261.
6. Chen YZ, Gao Q, Zhao XZ etal. Systematic review of TCF2 anomalies in renal cysts and diabetes syndrome/maturity onset diabetes of the young type 5. Chin Med J. 2010; 123: 3326-3333.
7. Edghill EL, Stals K, Oram RA, Shepherd MH, Hattersley AT, Ellard S. HNF1B deletions in patients with young-onset diabetes but no known renal disease. Diabet Med. 2013; 30: 114-117.
8. Pearson ER, Badman MK, Lockwood CR etal. Contrasting diabetes phenotypes associated with hepatocyte nuclear factor-1alpha and -1beta mutations. Diabetes Care. 2004; 27: 1102-1107.
9. Brackenridge A, Pearson ER, Shojaee-Moradie F, Hattersley AT, Russell-Jones D, Umpleby AM. Contrasting insulin sensitivity of endogenous glucose production rate in subjects with hepatocyte nuclear factor-1beta and -1alpha mutations. Diabetes. 2006; 55: 405-411.
10. Dungan KM. 1, 5-Anhydroglucitol (GlycoMark) as a marker of short-term glycemic control and glycemic excursions. Expert Rev Mol Diagn. 2008; 8: 9-19.